Skip to content

SADYAVRANA MANAGEMENT WITH PRITAHKPARNYADI ROPANA GHRITA

A CLINICAL STUDY ON SADYAVRANA AND ITS MANAGEMENT WITH PRITAHKPARNYADI ROPANA GHRITA - NIL

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/03/105516
Enrollment
60
Registered
2026-03-06
Start date
Unknown
Completion date
Unknown
Last updated
2026-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: T148- Other injury of unspecified body region

Interventions

None listed

Sponsors

Dr Riturekha Das
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patient irrespective of age occupation and sex will be considered for the study Patient having clinical features like pain discharge swelling redness and granulation tissue will be included Patient with wound duration less than 7 days

Exclusion criteria

Exclusion criteria: patient suffering from degeneration diseases patient suffering from lesions like TB diabetes syphilis leprosy burn and fistula in ano Patient having pregangrenous or gangrenous changes patient suffering from Hiv HbsAg

Design outcomes

Primary

MeasureTime frame
1 Effectiveness of the Prithakparnyadi Ropana Ghrita shall be evaluate according to sign and symptoms 2 Effectiveness of the mupirocin ointment shall be evaluate according to sign and symptomsTimepoint: 15 days

Secondary

MeasureTime frame
NilTimepoint: Nil

Countries

India

Contacts

Public ContactProff Dr Ranjan kumar Kasta

Gopabandhu Ayurveda Mahavidyalaya, Puri

drrkkasta@gmail.com9439809240

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Apr 4, 2026